These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
158 related articles for article (PubMed ID: 31489595)
21. Patient preferences and willingness-to-pay for ADHD treatment with stimulants using discrete choice experiment (DCE) in Sweden, Denmark and Norway. Glenngård AH; Hjelmgren J; Thomsen PH; Tvedten T Nord J Psychiatry; 2013 Oct; 67(5):351-9. PubMed ID: 23245636 [TBL] [Abstract][Full Text] [Related]
22. Association of Preferences for Papillary Thyroid Cancer Treatment With Disease Terminology: A Discrete Choice Experiment. Nickel B; Howard K; Brito JP; Barratt A; Moynihan R; McCaffery K JAMA Otolaryngol Head Neck Surg; 2018 Oct; 144(10):887-896. PubMed ID: 30140909 [TBL] [Abstract][Full Text] [Related]
23. Societal preferences for the return of incidental findings from clinical genomic sequencing: a discrete-choice experiment. Regier DA; Peacock SJ; Pataky R; van der Hoek K; Jarvik GP; Hoch J; Veenstra D CMAJ; 2015 Apr; 187(6):E190-E197. PubMed ID: 25754703 [TBL] [Abstract][Full Text] [Related]
24. Investigating the Heterogeneity in Women's Preferences for Breast Screening: Does the Communication of Risk Matter? Vass CM; Rigby D; Payne K Value Health; 2018 Feb; 21(2):219-228. PubMed ID: 29477404 [TBL] [Abstract][Full Text] [Related]
25. Eliciting preferences for outpatient care experiences in Hungary: A discrete choice experiment with a national representative sample. Brito Fernandes Ó; Péntek M; Kringos D; Klazinga N; Gulácsi L; Baji P PLoS One; 2020; 15(7):e0235165. PubMed ID: 32735588 [TBL] [Abstract][Full Text] [Related]
26. Adolescent girls' preferences for HPV vaccines: a discrete choice experiment. Brown DS; Poulos C; Johnson FR; Chamiec-Case L; Messonnier ML Adv Health Econ Health Serv Res; 2014; 24():93-121. PubMed ID: 25244906 [TBL] [Abstract][Full Text] [Related]
27. Preferences of Patients with Non-Communicable Diseases for Primary Healthcare Facilities: A Discrete Choice Experiment in Wuhan, China. Jia E; Gu Y; Peng Y; Li X; Shen X; Jiang M; Xiong J Int J Environ Res Public Health; 2020 Jun; 17(11):. PubMed ID: 32512772 [TBL] [Abstract][Full Text] [Related]
28. Estimating Preferences for Complex Health Technologies: Lessons Learned and Implications for Personalized Medicine. Marshall DA; Gonzalez JM; MacDonald KV; Johnson FR Value Health; 2017 Jan; 20(1):32-39. PubMed ID: 28212966 [TBL] [Abstract][Full Text] [Related]
29. Mimicking Real-Life Decision Making in Health: Allowing Respondents Time to Think in a Discrete Choice Experiment. Veldwijk J; Johansson JV; Donkers B; de Bekker-Grob EW Value Health; 2020 Jul; 23(7):945-952. PubMed ID: 32762997 [TBL] [Abstract][Full Text] [Related]
30. PARC report: a health-systems focus on reimbursement and patient access to pharmacogenomics testing. L Rogers S; Keeling NJ; Giri J; Gonzaludo N; Jones JS; Glogowski E; Formea CM Pharmacogenomics; 2020 Jul; 21(11):785-796. PubMed ID: 32748688 [TBL] [Abstract][Full Text] [Related]
31. Preferences for centralised emergency medical services: discrete choice experiment. Bhattarai N; Mcmeekin P; Price CI; Vale L BMJ Open; 2019 Nov; 9(11):e030966. PubMed ID: 31694847 [TBL] [Abstract][Full Text] [Related]
32. Hospital sector choice and support for public hospital care in New Zealand: Results from a labeled discrete choice survey. Brown P; Panattoni L; Cameron L; Knox S; Ashton T; Tenbensel T; Windsor J J Health Econ; 2015 Sep; 43():118-27. PubMed ID: 26232651 [TBL] [Abstract][Full Text] [Related]
33. Impact of Treatment Subsidies and Cash Payouts on Treatment Choices at the End of Life. Finkelstein E; Malhotra C; Chay J; Ozdemir S; Chopra A; Kanesvaran R Value Health; 2016; 19(6):788-794. PubMed ID: 27712706 [TBL] [Abstract][Full Text] [Related]
34. Relationship between the Uncompensated Price Elasticity and the Income Elasticity of Demand under Conditions of Additive Preferences. Sabatelli L PLoS One; 2016; 11(3):e0151390. PubMed ID: 26999511 [TBL] [Abstract][Full Text] [Related]
35. Advancing precision medicine in healthcare: addressing implementation challenges to increase pharmacogenetic testing in the clinical setting. Dong OM; Wiltshire T Physiol Genomics; 2017 Jul; 49(7):346-354. PubMed ID: 28550089 [TBL] [Abstract][Full Text] [Related]
36. Societal preferences for rheumatoid arthritis treatments: evidence from a discrete choice experiment. Harrison M; Marra C; Shojania K; Bansback N Rheumatology (Oxford); 2015 Oct; 54(10):1816-25. PubMed ID: 25989956 [TBL] [Abstract][Full Text] [Related]
37. Are Healthcare Choices Predictable? The Impact of Discrete Choice Experiment Designs and Models. de Bekker-Grob EW; Swait JD; Kassahun HT; Bliemer MCJ; Jonker MF; Veldwijk J; Cong K; Rose JM; Donkers B Value Health; 2019 Sep; 22(9):1050-1062. PubMed ID: 31511182 [TBL] [Abstract][Full Text] [Related]
38. The importance of population differences: Influence of individual characteristics on the Australian public's preferences for emergency care. Harris P; Whitty JA; Kendall E; Ratcliffe J; Wilson A; Littlejohns P; Scuffham PA Health Policy; 2018 Feb; 122(2):115-125. PubMed ID: 29157994 [TBL] [Abstract][Full Text] [Related]
39. How Do Members of the Duchenne and Becker Muscular Dystrophy Community Perceive a Discrete-Choice Experiment Incorporating Uncertain Treatment Benefit? An Application of Research as an Event. Bridges JFP; Tsai JH; Janssen E; Crossnohere NL; Fischer R; Peay H Patient; 2019 Apr; 12(2):247-257. PubMed ID: 30259384 [TBL] [Abstract][Full Text] [Related]
40. Adolescent values for immunisation programs in Australia: A discrete choice experiment. Wang B; Chen G; Ratcliffe J; Afzali HHA; Giles L; Marshall H PLoS One; 2017; 12(7):e0181073. PubMed ID: 28746348 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]